Study Summary
This trial will test a new injection to see if it helps people with advanced solid tumors who can't have standard treatment.
- Solid Tumors
- Metastatic Cancer
Treatment Effectiveness
Study Objectives
3 Primary · 3 Secondary · Reporting Duration: 12 months
Trial Safety
Trial Design
1 Treatment Group
CAN1012 single agent
1 of 1
Experimental Treatment
36 Total Participants · 1 Treatment Group
Primary Treatment: CAN1012 · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 80 · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Florida | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Providence Cancer Institute | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Frequently Asked Questions
Has CAN1012 been officially sanctioned by the Food and Drug Administration?
"Due to the limited data of efficacy and safety, our team at Power believes CAN1012 is a safe option, thus assigning it a score of 1." - Anonymous Online Contributor
Has recruitment commenced for this clinical experiment?
"Affirmative. Clinicaltrials.gov verifies that recruitment for this clinical trial is ongoing, having started on December 1st 2021 and most recently updated on February 22nd 2022. This investigation requires 36 participants to be enrolled from two separate sites." - Anonymous Online Contributor
Are the eligibility requirements for this clinical experiment inclusive of individuals aged 45 and over?
"This clinical trial is open to individuals aged between 18 and 80. Separately, there are 327 trials for minors under the age of 18 as well as 2505 studies catered towards elderly citizens over 65 years old." - Anonymous Online Contributor
How many individuals have been enrolled in this trial thus far?
"Confirmed, current information on clinicaltrials.gov reveals that this trial is still open for participants. This experiment was first advertised on December 1st 2021 and its most recent amendment was made on February 22nd 2022; the study intends to recruit 36 people from 2 sites." - Anonymous Online Contributor
Are there specific criteria to join this medical experiment?
"The requirements necessary to be included in this clinical trial necessitate a metastatic cancer diagnosis, and the patient must lie between 18-80 years old. Around 36 people are accepted into the study." - Anonymous Online Contributor